Stock Price
71.22
Daily Change
1.86 2.68%
Monthly
-1.04%
Yearly
105.25%
Q3 Forecast
68.78

Corcept Therapeutics reported $443.11M in Current Assets for its fiscal quarter ending in June of 2025.




Current Assets Change Date
Acadia Pharmaceuticals USD 960.55M 89.61M Jun/2025
Alaunos Therapeutics USD 2.76M 795K Dec/2024
ANI Pharmaceuticals USD 602.63M 66.34M Jun/2025
Ardelyx USD 351.57M 4.88M Jun/2025
Aurora Cannabis CAD 465.3M 28.91M Jun/2025
BioMarin Pharmaceutical USD 3.81B 337.43M Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Canopy Growth CAD 303.36M 37.72M Jun/2025
Corcept Therapeutics USD 443.11M 4.61M Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Merck USD 37.07B 1.56B Jun/2025
Novartis USD 25.94B 831M Jun/2025
Novartis USD 25.94B 3.76B Jun/2025
Pacira USD 745.61M 14.35M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Supernus Pharmaceuticals USD 738.87M 51.28M Jun/2025
TG Therapeutics USD 663.96M 19.45M Jun/2025